drugset / Trial / NCT03031210

Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.

NCT03031210

Phase 2/3 Recruiting 1370 enrolled St. Justine's Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study will be to evaluate whether a twice-daily antibiotic regimen is non-inferior to a thrice-daily regimen for the treatment of non-severe community acquired pneumonia in children presenting at a paediatric Emergency Department (ED).

Timeline

Start
2017-06-11
Primary completion
2027-06-01
Completion
2027-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 90 mg/kg

Indications